Civic AI
Procurement intelligence
Federal contract award
EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL. INCORPORATE FAR 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APRIL 2026) TO COMPLY WITH UPDATED FAR GUIDANCE IMPLEMENTING EXECUTIVE ORDER 14398.
ABT GLOBAL LLC · Department of Health and Human Services
- Value
- $6,387,451
- Start
- Aug 16, 2024
- End
- Aug 15, 2027
- Action date
- May 18, 2026
- PIID
- 75FCMC24F0164
- Status
- active
- NAICS
- 541720 · RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES
- Place of performance
- WINDSOR MILL, MD
- Award type
- DELIVERY ORDER
Description
EVALUATION OF THE CELL AND GENE THERAPY ACCESS MODEL. INCORPORATE FAR 52.222-90 ADDRESSING DEI DISCRIMINATION BY FEDERAL CONTRACTORS (APRIL 2026) TO COMPLY WITH UPDATED FAR GUIDANCE IMPLEMENTING EXECUTIVE ORDER 14398.
Need modifications, related awards, and vendor peers? Open the full award workspace.